Kukje Pharma Co., Ltd. (KRX:002720)
South Korea · Delayed Price · Currency is KRW 3,430.00
+85.00 (2.54%)
Nov 2, 2026, 3:30 PM KST
Kukje Pharma Market Cap
Kukje Pharma has a market cap or net worth of 72.58 billion as of November 2, 2026. It is the 29,559th most valuable company in the world and the 1,491st biggest in South Korea. Its market cap has decreased by 16.43% in one year.
Market Cap
72.58B
Enterprise Value
88.25B
Revenue
181.27B
Global Rank
Country Rank
#1,491 South Korea
PE Ratio
14.27
ChartMarket Cap Chart
Since July 3, 2006, Kukje Pharma's market cap has increased from 29.64B to 72.58B, an increase of 144.86%. That is a compound annual growth rate of 4.50%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 2, 2026 | 72.58B | -17.11% |
| Dec 30, 2025 | 87.56B | -15.02% |
| Dec 30, 2024 | 103.03B | -14.06% |
| Dec 28, 2023 | 119.89B | 12.98% |
| Dec 29, 2022 | 106.12B | -5.98% |
| Dec 30, 2021 | 112.86B | -36.19% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Ilyang Pharmaceutical Co.,Ltd | 124.76B |
| Kyongbo Pharmaceutical | 122.88B |
| SAMSUNG PHARM. Co., LTD. | 113.23B |
| Dong Sung Bio Pharm.Co.,Ltd. | 112.29B |
| HANDOK | 106.66B |
| Jeil Pharma Holdings | 103.16B |
| Enzychem Lifesciences | 76.86B |
| CKD Bio | 67.64B |